Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03838367
Title Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors CytoDyn, Inc.

triple-receptor negative breast cancer


Carboplatin + Leronlimab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.